Unsuccessful suicidal attempts by sewing needle introducing to chest: removing 17 ones from the right ventricle and breast tissue in two stages; case report and literature review - Mohammadzadeh A, Khanghah AS, Ojarood MV.
INTRODUCTION AND IMPORTANCE: Penetrating cardiac injuries among the whole injuries confronting the trauma surgeon is more alarming. The introduction of needles as an attempt to inflict self-injury has rarely been described, so we only found 34 reported cas... (Source: SafetyLit)
Source: SafetyLit - April 8, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Cryoablation effective in women with breast cancer
A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors, according to a study presented March 27 at the Society of Interventional Radiology (SIR) meeting in Salt Lake City.
The finding suggests the technique may provide a new treatment path for women who are not candidates for lumpectomy, or surgical removal, noted Yolanda Bryce, MD, an interventional radiologist at Memorial Sloan Kettering Cancer Center in New York City, and senior author of the study.
“Surgery is still the best option for tumor removal, but there are ...
Source: AuntMinnie.com Headlines - March 27, 2024 Category: Radiology Authors: Will Morton Tags: Interventional Breast Source Type: news
Imaging surveillance suggested for radial scars found on DBT
Imaging surveillance may be the way to go for monitoring radial scars without atypia found on screening digital breast tomosynthesis (DBT), research published March 13 in the American Journal of Roentgenology found.
In a study, Claire Crowley and Manisha Bahl, MD, from Massachusetts General Hospital in Boston, found that screening-detected radial scars without atypia at core-needle biopsy have a low upstaging rate to breast cancer of less than 2%.
“Our results, which show that surgical excision is not necessary for all patients with radial scars, could lead to a reduction in unnecessary surgery and could save patients ...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
CEUS shines in diagnostic, interventional settings
Dynamic contrast-enhanced ultrasound (CEUS) is a useful tool for interventions, according to a March 3 presentation given at ECR 2024. In his talk, Dean Huang, MD, from King’s College London in England outlined novel applications for CEUS in vascular and nonvascular imaging, as well as therapeutic and potential future applications. “Ultrasound contrast agent use can be ubiquitous in interventional practice and can solve many logistical or clinical diagnostic problems,” he said. “And we can achieve all of this without the use of radiation and nephrotoxicity.” Dean Huang, MD, from King's College London highligh...
Source: AuntMinnie.com Headlines - March 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Low-dose PEM shows promise in breast cancer detection
Low-dose positron emission mammography (PEM) can detect invasive breast cancer in a feasible manner, according to research published February 9 in Radiology: Imaging Cancer.
A team led by Vivianne Freitas, MD, from the University of Toronto found that PEM performed comparably to MRI in breast cancer detection and could serve as a supplemental imaging method for evaluating dense breasts.
"This groundbreaking imaging technique presents a compelling alternative, mirroring the clinical utility of traditional mammography and MRI but utilizing considerably lower doses of radiation when compared with previously molecular breast...
Source: AuntMinnie.com Headlines - February 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Is interventional radiology ready for augmented reality?
Augmented reality (AR) systems may enhance image-guided tumor ablations by improving the accuracy of needle placements, according to a study published January 29 in the Journal of Medical Imaging and Radiation Sciences.
In a medical literature review, a group at McMaster University in Ontario, Canada, said they found compelling evidence that AR can offer interventional radiologists real-time guidance and enhanced visualization during these procedures, noted first author Yousif Al-Naser and colleagues.
“These findings collectively support the potential benefits of AR systems in enhancing image-guided tumor ablations,”...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Will Morton Tags: Interventional Radiology Source Type: news
ChatGPT gives'mostly' appropriate responses for breast pathology
ChatGPT could be an accessible source of information for women waiting to discuss core-needle breast biopsy results with their healthcare practitioners, a study published January 3 in the American Journal of Roentgenology found.
Researchers led by Eniola Oluyemi, MD, from Johns Hopkins University in Baltimore, MD found that the chatbot provided “mostly appropriate” responses to various questions regarding breast pathologic diagnoses as rated by reviewers.
“The reviewers’ overall agreement ranged from 88% to 96% regarding responses’ accuracy, consistency, definition provided, and clinical significance conveyed,...
Source: AuntMinnie.com Headlines - January 5, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Advanced Visualization Breast Imaging Source Type: news
They proudly served their adoptive nation – and found a path to medicine along the way
When Jose Chevalier, Isabelle Trinh Phan and Nam Yong Cho enlisted in the U.S. military, they were thinking of their families. Their families were, after all, the strongest support system these three Bruins had after immigrating to the U.S. from various parts of the globe, and joining up meant easing the pressure on their loved ones. But it was a good thing for a variety of reasons.While none of these student veterans could have predicted it, their military experiences would also point them toward academic and career trajectories in medicine, eventually leading two of them to theDavid Geffen School of Medicine at UCLA and ...
Source: UCLA Newsroom: Health Sciences - November 9, 2023 Category: Universities & Medical Training Source Type: news
Combined ultrasound, MRI characterizes nonmass-like breast lesions
Combining ultrasound with MRI could help better differentiate between benign and malignant breast nonmass-like lesions initially detected on ultrasound, a study published October 12 in Ultrasound in Medicine & Biology found. Researchers led by Rui-Lan Niu, PhD, from the Chinese PLA General Hospital in Beijing, China, found that their combined method led to improved performance in this area over each modality alone.
“The study determined that the integrated diagnostic strategy had good performance in the diagnosis of nonmass-like lesions, which can improve diagnostic specificity while maintaining high sensitivity,” Ni...
Source: AuntMinnie.com Headlines - October 13, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Womens Imaging Breast Source Type: news
Behavior Is a Miracle Drug for Our Health
Healthcare is broken. Chronic diseases are eating up an increasing share of healthcare resources in every healthcare system across the world in ways that are not sustainable. Yes, there is a golden age of innovation happening in the form of new technologies like gene therapy, neural technology, immunotherapy, and increasingly the impact of AI on diagnoses and drug development, but we can’t let these extraordinary technological advances blind us to the tragedy of modern healthcare and to the much neglected miracle drug right in front of us: our daily behaviors. Whether for preventing disease or optimizing the treatmen...
Source: TIME: Health - August 31, 2023 Category: Consumer Health News Authors: Arianna Huffington Tags: Uncategorized freelance Source Type: news
Antithrombotic therapy safe to continue during breast biopsy
Women can safely continue antithrombotic therapy during breast core-needle biopsy...Read more on AuntMinnie.comRelated Reading:
USPSTF calls for biennial mammography screening as of age 40
SBI: The presence of LCIS indicates increased breast cancer risk
Mammo-guided vacuum-assisted biopsy effective for thin breast tissue
SBI: DCIS progression appears as new masses on surveillance imaging
ACR releases updated breast cancer screening recommendation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2023 Category: Radiology Source Type: news
New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Through Four Years in Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final data from the long-term extension (LTE) of the Phase 3 UNIFI study demonstrating efficacy and safety of STELARA® (ustekinumab) through four years of treatment in adult patients with moderately to severely active ulcerative colitis (UC).1 Among all patients who had achieved clinical responsea with STELARA during induction, 64.9 percent were in symptomatic remissionb after 44 weeks of maintenance. At week 200 (four years), this proportion of patients was 55.2 percent; the majority (96.4 percen...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
